Impulse control disorders in Chinese Parkinson's disease patients: The effect of ergot derived dopamine agonist

Parkinsonism and Related Disorders

Volumn 17, Issue 8, 2011, Pages 635-637

  Auyeung, M ^a   Tsoi, T H ^a   Tang, W K ^b   Cheung, C M ^a   Lee, C N ^a   Li, R ^a   Yeung, Eric ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bromocriptine; Chinese; Ergot derived dopamine agonists; Impulse control disorders; Parkinson's disease

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOT DERIVATIVE; LEVODOPA; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

AGED; ANXIETY; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 80052349869     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.06.001     Document Type: Article

References (12)

1. Voon V., Hassan K., Zurowski M. Prospective prevalence of pathological. gambling and medication association in Parkinson's disease, gambling and medication association in Parkinson's disease. Neurology 2006, 66:1750-1752.
2. Weintraub D., Siderowf A.D., Potenza M.N. Association of dopamine agonist use with impulse control disorders in Parkinson disease, agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006, 63:969-973.
3. Voon V., Hassan K., Zurowski M., de Souza M., Thomsen T., Fox S., et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006, 7:1254-1257.
4. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V., et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595.
5. Gallagher David A., O'Sullivan Sean S., Evans Andrew H., Lees Andrew J., Schrag Anette Pathological gambling in Parkinson's disease Risk Factors and differences from DDS. Analysis of published case series. Mov Disord 2007, 12:1757-1763.
6. Fan W.H., Ding H., Ma J.H., Chan P. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett 2009, 465:6-9.
7. Weintraub Daniel, Hoops Staci, Shea Judy A., Lyons Kelly E. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009, 10:1461-1467.
8. Voon Valerie, Potenzac Marc N., Thomsen Teri Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 2007, 20:484-492.
9. Lee Jee-Young, Kim Jong-Min, Woo Kim Jae, Cho Jinwhan, Yong Lee Won, Kim Han-Joon, et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 2010, 16:202-207.
10. Pontone G., Williams J.R., Bassett S.S., Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006, 7:1258-1261.
11. Chen C.-N., Wong J., Lee N., Chan-Ho M.-W., Lau.J T.-F., Fung M. The shatin community mental health survey in Hong Kong: II major findings. Arch Gen Psychiatry 1993, 50:125-133.
12. Sohtaoglu Melis, Demiray Derya Yavuz, Kenangil Gülay, Özekmekçi Sibel, Erginöz Ethem Long term follow-up of Parkinson's disease patients with impulse control disorders. Parkinsonism Relat Disord 2010, 16:334-337.